Future TOC

Volume 27, Number 4 (August 2020)

Based on the author provided metadata and may not accurately reflect the final Table of Contents



Chest Wall Toxicity after Stereotactic Radiation in Early Lung Cancer: A Systematic Review
I. S. Voruganti, E. Donovan, C. Walker-Dilks, A. Swaminath

Risk Factors for Venous Thromboembolism in Endometrial Cancer
S. Pin, J. E. Mateshaytis, S. Ghosh, E. Batuyong, J. C. Easaw

Retrospective cohort study of unresectable stage III non-small cell lung cancer in Canada
S. J. Seung, M. Hurry, R. N. Walton, W. K. Evans

Cardiovascular risk factors are at age-dependent increased odds among cancer survivors: CLSA cohort
A. A. Kirkham

Canadian cohort expanded access program of nivolumab plus ipilimumab in advanced melanoma
D. Hogg, J. G. Monzon, S. Ernst, X. Song, E. McWhirter, K. J. Savage, B. Skinn, F. Romeyer, M. Smylie

Breast cancer diagnosis and treatment wait times in specialized diagnostic units versus usual care
C. Webber, M. Whitehead, A. Eisen, C. MB. Holloway, P. A. Groome

A Cost-Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer
A. Parmar, M. Richardson, P. C. Coyte, S. YS. Cheng, B. Sander, K. KW. Chan

CAMO Abstracts
A. Campbell

The importance of humor in oncology: A survey of patients undergoing radiotherapy
R. S. Samant, K. Balchin, E. Cisa-Pare, J. Renaud, L. Bunch, A. McNeil, S. Murray, J. Meng

Real world treatment patterns and survival of stage IV non-small cell lung cancer in Canada
S. J. Seung, M. Hurry, R. N. Walton, W. K. Evans

Severe cytomegalovirus gastritis after pembrolizumab in a patient with melanoma
H. Kim, S. Y. Ha, J. Kim, M. Kang, J. Lee

Sequence of Therapy and Survival among Patients with Advanced Pancreatic Neuroendocrine Tumors
Erica S. Tsang

Cigarette smoking characteristics and interest in cessation in head and neck cancer patients
M. SC. Conlon

Impact of Dissemination of Choosing Wisely Canada Guidelines on Utilization of Palliative Single Fraction Radiotherapy at a Provincial Cancer Program
J. O. Kim

Cutaneous paraneoplastic syndrome associated with anal squamous cell carcinoma: A rare presentation of an uncommon cancer
R. Park

Nivolumab and ipilimumab immunotherapy for hemodialysis patients with advanced renal cell carcinoma
Y. Kobayashi, H. Arai, M. Honda

Association between known risk factors and colorectal cancer risk among Indigenous people participating in the Ontario Familial Colon Cancer Registry
S. Jamal, A. J. Sheppard, M. Cotterchio, S. Gallinger

The case for breast conservation treatment rates to be a quality metric
M. P. Tan, E. Silva


Upcoming in Current Oncology

Quality of life in a real-world study of metastatic colorectal cancer patients treated with trifluridine/tipiracil (FTD/TPI)
W.Y. Cheung, P. Kavan, A. Dolley

Prognostic utility of neutrophil-to-lymphocyte ratio in metastatic colorectal cancer patients treated with different modalities
G. Nogueira-Costa

H. S. Wald

A pan-Canadian prospective study of young women with breast cancer: The Rationale and Protocol Design for the RUBY study
M. Quan, I.A. Olivotto, N.N. Baxter, C.M. Friedenreich, K. Metcalfe, E. Warner, K. MacLennan, J.E. Stephen, M.R. Akbari, D. Howell, S Narod and the RUBY Site Investigators.

A clinical investigation of the association between perioperative oral management and prognostic nutritional index in digestive and urinary cancer patients
S. Yamada

The Risk of Gastrointestinal Toxicity in Patients with Lung Cancer Treated with Immune-Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
K. Bishay, P. Tandon, S. Bourassa-Blanchette, S. A. Laurie, J. D. McCurdy

Delay in diagnosis of patients with head and neck cancer in Canada: impact of patient and provider delay
S. Kassirian, A. Dzioba, S. Hamel, K. Patel, D. Palma, V. Venkatesan, A. Nichols, J. Yoo, K. Fung, A. Mendez, S. D. MacNeil

The Prevention and Treatment of Cancer-associated Thrombosis
M. Carrier, S. Ng

Multicentric Chondrosarcoma Involving the Appendicular Skeleton: A Case Report and Literature Review
V. Aran, W. Meohas, A. C. de Sa Lopes, L. M. Cabral, A. F. Costa, J. A. M. Guimar√£es, M. E. L. Duarte

Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada
Y. Y. R. Li

Understanding clinical practice and survival outcomes in patients with stage III, unresectable non-small cell lung cancer in a single-centre in Quebec, Canada
G. Kasymjanova, J. S. Agulnik, C. Pepe, M. Hurry, R. N. Walton, L. Sakr, V. Cohen, M. Lecavalier, D. Small

Improving Formative Assessments in Canadian Medical Oncology Residency Training
R. Arora, S. D. Mukherjee

Osteopontin Level and Promoter Polymorphism in Egyptian Metastatic Breast Cancer Patients
M. A. Elbaiomy, T. Akl, W. El-Beshbishi, R. Elhelaly, R. Elzehery, M. El-Ghonemy

Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre
M. Nadjafi, M. Sung, G. da Cunha Santos, L. Le, D. Hwang, M. Tsao, N. Leighl